9R2F image
Deposition Date 2025-04-30
Release Date 2025-06-11
Last Version Date 2025-10-22
Entry Detail
PDB ID:
9R2F
Keywords:
Title:
Tau filaments seeded by AD homogenate using 0N3R C322A
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.80 Å
Aggregation State:
FILAMENT
Reconstruction Method:
HELICAL
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Isoform Fetal-tau of Microtubule-associated protein tau
Gene (Uniprot):MAPT
Chain IDs:A, B, C, D, E, F
Chain Length:72
Number of Molecules:6
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Serial amplification of tau filaments using Alzheimer's brain homogenates and C322A or C322S recombinant tau.
Febs Lett. 599 2768 2778 (2025)
PMID: 41026859 DOI: 10.1002/1873-3468.70141

Abstact

The assembly of tau into amyloid filaments is a hallmark of Alzheimer's disease (AD) and other tauopathies. Cryo-EM revealed the existence of disease-specific tau folds, which are challenging to replicate in vitro. We studied three full-length recombinant 0N3R tau forms (the wild-type and the C322A and C322S variants) using an RT-QuIC assay with brain homogenate seeding. C322A tau formed filaments resembling AD paired helical filaments (PHFs) but with a more open C-shaped core. C322S tau yielded structurally distinct filaments with an ordered C-terminal region. Both mutants seeded further aggregation, whereas the wild-type showed poor reproducibility and mainly unfolded aggregates. These results highlight the importance of optimised conditions to produce disease-relevant tau filaments and aid the development of targeted therapies. Impact statement We investigated the seeded assembly of 0N3R tau and its two mutational variants C322A and C322S, using Alzheimer's disease brain homogenates in a real-time quaking-induced conversion (RT-QuIC) assay. The C322A variant formed filaments partially resembling the AD PHF structure, showing the importance of optimised conditions to produce disease-relevant tau filaments.

Legend

Protein

Chemical

Disease

Primary Citation of related structures